Literature DB >> 12700949

Immunotoxins containing Pseudomonas exotoxin A: a short history.

Ira Pastan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700949     DOI: 10.1007/s00262-002-0353-8

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.630


× No keyword cloud information.
  19 in total

1.  The antimelanoma immunocytokine scFvMEL/TNF shows reduced toxicity and potent antitumor activity against human tumor xenografts.

Authors:  Yuying Liu; Weihe Zhang; Lawrence H Cheung; Ting Niu; Qingping Wu; Chun Li; Carolyn S Van Pelt; Michael G Rosenblum
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

Review 2.  Novel bacterial ADP-ribosylating toxins: structure and function.

Authors:  Nathan C Simon; Klaus Aktories; Joseph T Barbieri
Journal:  Nat Rev Microbiol       Date:  2014-07-14       Impact factor: 60.633

3.  Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia.

Authors:  Francis Mussai; Dario Campana; Deepa Bhojwani; Maryalice Stetler-Stevenson; Seth M Steinberg; Alan S Wayne; Ira Pastan
Journal:  Br J Haematol       Date:  2010-06-07       Impact factor: 6.998

4.  Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial.

Authors:  Alan S Wayne; Robert J Kreitman; Harry W Findley; Glen Lew; Cynthia Delbrook; Seth M Steinberg; Maryalice Stetler-Stevenson; David J Fitzgerald; Ira Pastan
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

5.  In vitro and in vivo anti-tumor activities of anti-EGFR single-chain variable fragment fused with recombinant gelonin toxin.

Authors:  Xikun Zhou; Ji Qiu; Zhen Wang; Nongyu Huang; Xiaolei Li; Qian Li; Yinbing Zhang; Chengjian Zhao; Can Luo; Nannan Zhang; Xiu Teng; Zhongwen Chen; Xiao Liu; Xianlian Yu; Wenling Wu; Yu-quan Wei; Jiong Li
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-07       Impact factor: 4.553

Review 6.  Strategies to Reduce the Immunogenicity of Recombinant Immunotoxins.

Authors:  Ronit Mazor; Emily M King; Ira Pastan
Journal:  Am J Pathol       Date:  2018-06-02       Impact factor: 4.307

7.  Isolation of anti-CD22 Fv with high affinity by Fv display on human cells.

Authors:  Mitchell Ho; Satoshi Nagata; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-08       Impact factor: 11.205

8.  In vitro and in vivo antitumor effects of the recombinant immunotoxin IL6(T23)-PE38KDEL in multiple myeloma.

Authors:  DE-Jun Guo; Jia-Shan Han; Yan-Song Li; Zeng-Shan Liu; Shi-Ying Lu; Hong-Lin Ren
Journal:  Oncol Lett       Date:  2012-05-25       Impact factor: 2.967

9.  An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo.

Authors:  Melissa C Cheung; Leigh Revers; Subodini Perampalam; Xin Wei; Reza Kiarash; David E Green; Aws Abdul-Wahid; Jean Gariépy
Journal:  Mol Cancer       Date:  2010-02-03       Impact factor: 27.401

10.  EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cells.

Authors:  Hidenobu Ochiai; Gary E Archer; James E Herndon; Chien-Tsun Kuan; Duane A Mitchell; Darell D Bigner; Ira H Pastan; John H Sampson
Journal:  Cancer Immunol Immunother       Date:  2007-07-19       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.